EXPE Expedia Group, Inc. Insider Trading

Expedia CLO Robert Dzielak sold 4,702 shares ($1.1M) at $233.00 on 2026-06-05; stock now $225.90, -25.6% from 52-week high.

Robert J Dzielak, Chief Legal Officer and Secretary of Expedia Group, sold 4,702 shares for $1.1M total value, reducing his holdings by -4.3% to 105.4K shares. The transaction occurred at $233.00, but the stock has declined to $225.90 and sits -25.6% below its 52-week high of $303.80. Across his same-ticker history at EXPE, Dzielak's 5 prior trades show mixed timing: 2 of 5 were well-timed at the 90-day mark, with returns ranging from -21.0% to +33.5%. Against his broader cross-ticker track record, 13 prior sells averaged a -0.3% 30-day return and +16.3% 90-day return, with a 20.00% well-timed rate, indicating his sales historically have captured some downside moves. The company's fundamentals show positive annual revenue growth of +7.6% and a P/E of 17.38, though the most recent quarter posted a -$6.0M net loss despite $3.4B in revenue.

Expedia CLO Dzielak sold 8,225 EXPE shares at $220.82 on 2026-03-04 for $1.8M; stock now at $251.54

Dzielak sold 8,225 shares (7.4% of pre-transaction holdings) at $220.82, reducing his position from 110.7K to 102.5K shares. The current price of $251.54 is 13.9% above the transaction price, indicating the sale was not well-timed at the immediate 90-day window—a pattern consistent with his EXPE trade history, where only 2 of 5 prior same-ticker sells showed negative 90-day returns. His cross-ticker track record shows an average 90-day return of +17.8% after sells (poorly timed at that horizon), though his well-timed rate of 22.22% suggests modest success timing exits across all holdings. The $1.8M transaction is material in absolute terms but modest relative to his ~$25.8M post-transaction EXPE position valuation at current prices, suggesting this is a small allocation adjustment rather than a signal of conviction loss at the executive level.

CLO Robert Dzielak sold 5,964 shares of EXPE over two days for $1,210,381.83, retaining 74,417 shares

Dzielak completed two separate sales totaling 5,964 shares for $1,210,381.83 at a blended average price of $202.95, reducing his position by 7.4% to 74,417 shares. At the current price of $207.20 (only 1.2% below the 52-week high of $209.68), the stock has appreciated 15.8% over the past 30 days and 24.3% over 90 days. Among his prior five trades at EXPE, only 2 of 5 were well-timed at the 90-day mark, and his cross-ticker track record shows a 28.57% well-timed rate with an average 90-day return of +14.0% after sells—indicating his sales have generally been poorly timed as the stock continued to appreciate. The transaction occurs against solid fundamentals: EXPE reported $3.8B in revenue with 6.6% annual growth and a net income of $330.0M, at a P/E of 22.14, making this a measured, position-reduction sale rather than a clear signal of concern.

Khosrowshahi sells 10,000 shares of Expedia at avg $196.27 on 2025-03-03; now holds 148,505 shares (-6.3%)

Director Dara Khosrowshahi executed 8 separate sales totaling 10,000 shares for $1,962,673.02 on 2025-03-03, with a blended average price of $196.27. The current stock price of $188.70 is 8.6% below the 52-week high, and the transaction occurred at prices that were above current levels. Khosrowshahi's cross-ticker track record shows a 90-day well-timed rate of 0.00% across 20 prior sells, suggesting his historical timing at other securities has not been strong. At EXPE specifically, all 5 prior measurable trades occurred on 2025-02-03 with outcomes not yet determinable, preventing direct comparison of his timing patterns at this ticker.

Chief Legal Officer Robert J Dzielak sold 5,000 EXPE shares at $205.70 on 2025-02-19 (1.0M value)

Robert J Dzielak, Chief Legal Officer & Secretary, sold 5,000 shares at $205.70, reducing his post-transaction holdings to 74,502 shares (−6.3% vs pre-transaction). The stock is trading at $206.52, within 0.0% of its 52-week high, and has appreciated 10.3% over the prior 30 days and 12.5% over 90 days. At Expedia (EXPE), Dzielak's prior three measurable sales (Aug 2024–Nov 2024) returned +3.2–3.8% in the 30-day window and +14.7–37.1% over 90 days—all positive outcomes that indicate the stock continued rising after his prior sales, meaning 0 of 3 were well-timed. The most recent prior sale on 2025-02-12 is too recent for outcome measurement. Expedia's fundamentals show $4.1B quarterly revenue, $684.0M net income, a P/E of 16.93, and 6.6% annual revenue growth, indicating stable operational performance and near-peak valuations at the 52-week high. This sale fits a pattern of regular liquidation activity in a well-performing security rather than a pre-emptive risk signal.

Dzielak sold 4,869 shares of EXPE at $203.00 on 2025-02-12 for $988,407.00; retains 76,196 shares.

Chief Legal Officer Dzielak Robert J sold 4,869 shares (-6.0% of pre-transaction holdings) at $203.00, near the 52-week high of $203.20. His prior trades at EXPE have not been well-timed at the 90-day mark: all 3 measurable prior sales (2024-08-14, 2024-08-15, 2024-08-19) were followed by positive 90-day returns of +37.8%, +37.1%, and +34.7% respectively, meaning the stock rose after he sold. Across his cross-ticker track record, his 8 prior sales averaged +36.5% 90-day return with a 0.00% well-timed rate, indicating a consistent pattern of selling before rallies. At current price of $202.38, the stock is -0.4% from the 52-week high where the sale occurred.

Director Khosrowshahi sells 10,000 shares of EXPE at $169.79 avg; holds 158.5K shares post-transaction.

On 2025-02-03, Director KHOSROWSHAHI DARA executed five separate sales totaling 10,000 shares for $1,697,940.45 at a blended average price of $169.79, reducing his holdings from 168.5K to 158.5K shares (-5.9%). The sales occurred across a narrow price range ($166.77–$170.86), and the current stock price of $168.47 sits 11.8% below the 52-week high and down 9.5% over 30 days. Within his prior trades at Expedia, four recent sells on 2025-01-02 have already shown negative 30-day returns (-6.9% to -8.9%), consistent with the current down-trend. His cross-ticker track record shows a 90-day well-timed rate of 18.18% across 20 prior sells, indicating mixed historical timing precision. The sale size (-5.9% of pre-transaction holdings) is moderate, and the company remains fundamentally healthy with $4.1B quarterly revenue, $684.0M net income, and a P/E of 19.48; however, the clustering of director sales in early February alongside near-term price weakness merits investor monitoring.

EXPE director Dara Khosrowshahi sold 10,000 shares for $1.9M on Jan 2 at blended avg $185.15; retains 168.5K shares

On January 2, 2025, Dara Khosrowshahi executed five separate sales totaling 10,000 shares for $1,851,527.73 at prices ranging from $183.68 to $187.61, reducing his stake from 178.5K to 168.5K shares (-5.6%). The stock is currently trading at $185.33, near his blended sale price of $185.15, and has appreciated 23.0% over the past 90 days and +0.9% over the past 30 days. His prior sales at EXPE (five trades since November 2024) have shown mixed near-term returns of -0.1% to +17.3% at the 30-day mark, with no 90-day outcomes yet measurable for timing assessment. Against fundamentals showing $4.1B in quarterly revenue, $684.0M net income, and a P/E of 21.43, the sale appears proportionate to his substantial remaining holding rather than a signal of strategic conviction shift.

EXPE Director Khosrowshahi sells 10,000 shares at blended avg $184.66 (4 transactions) on 2024-12-02

Dara Khosrowshahi, Director of Expedia Group, executed 4 separate sales totaling 10,000 shares for $1,846,552.81 on 2024-12-02 at prices ranging from $183.53 to $186.57, reducing his stake by 5.3% to 178,505 shares post-transaction. The stock is currently at $183.69, trading -1.4% from its 52-week high of $186.28, and has appreciated +15.2% over the past 30 days and +36.2% over 90 days. Across his cross-ticker open-market history, Khosrowshahi's 17 prior sells achieved an average 90-day return of +10.0% with a 38.46% well-timed rate, indicating his prior sales at other tickers have occurred before price declines less than half the time. At EXPE specifically, his most recent prior sales on 2024-11-01 and 2024-10-04 showed positive 30-day returns (+17.8%, +17.3%, +6.1%), though only one measurable 90-day outcome is available (2024-02-01 sale, which returned -11.3% and was well-timed). The filing represents a discrete reduction in a large holding during a period of strong near-term stock price momentum, with current liquidity at $22.7B market cap and solid fundamentals (P/E 21.24, FY revenue growth +10.0%).

CLO Robert Dzielak sold 5,536 shares at $180–$185 for $1,014,405 on 11/21–22; stock now at $184.92, near 52-week high

Dzielak, Chief Legal Officer, executed two separate sales totaling 5,536 shares for $1,014,405, reducing his EXPE holdings by 6.3% to 81,665 shares post-transaction. The sales occurred at $180.00 and $185.00 across two consecutive trading days, with a blended average price of $183.24; the current price of $184.92 sits at the 52-week high (+0.0% from high, +16.8% in 30 days, +33.9% in 90 days). His prior EXPE sales over the past 14 months yielded positive 90-day returns (+34.7%, +37.1%, +37.8%), suggesting the stock has consistently rallied after his sales at this ticker. The cumulative lack of well-timed downside outcomes (0 of 3 prior measurable EXPE sales preceded declines) contrasts with his broad cross-ticker track record of 6 prior sells averaging +36.5% over 90 days, indicating his sales at Expedia have not preceded price declines.